Trxade Group, Inc. (MEDS)
|Net Income (ttm)||-719,096|
|Trading Day||January 15|
|Day's Range||5.70 - 6.09|
|52-Week Range||4.10 - 7.96|
TAMPA, FL, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. ( MEDS ) an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the D...
Trxade Group Inc. (NASDAQ: MEDS) shares jumped on Tuesday after the company announced that it entered into a definitive agreement with Amazon.com Inc.
Shares of Trxade Group Inc. soared 56% in active trading to pace all of the premarket's gainers Tuesday, after the online platform for pharmaceutical purchases announced a market program agree...
Trxade Group, together with its subsidiaries, owns and operates a business-to-business (B2B) web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; Integra Pharma, LLC; and Other segments. The company operates a web based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a web-based pharmaceutical marketplace; InventoryRx.co... [Read more...]
|IPO Date |
Feb 13, 2020
Surendra K. Ajjarapu
|Stock Exchange |
|Ticker Symbol |
According to 3 analysts, the average rating for Trxade Group stock is "Buy." The 12-month stock price forecast is 12.17, which is an increase of 107.33% from the latest price.